Advertisement
U.S. markets closed
  • S&P Futures

    5,206.50
    -8.25 (-0.16%)
     
  • Dow Futures

    39,198.00
    -25.00 (-0.06%)
     
  • Nasdaq Futures

    18,172.50
    -59.00 (-0.32%)
     
  • Russell 2000 Futures

    2,047.20
    -2.60 (-0.13%)
     
  • Crude Oil

    82.56
    -0.16 (-0.19%)
     
  • Gold

    2,163.80
    -0.50 (-0.02%)
     
  • Silver

    25.30
    +0.03 (+0.12%)
     
  • EUR/USD

    1.0875
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    4.3400
    +0.0360 (+0.84%)
     
  • Vix

    14.33
    -0.08 (-0.56%)
     
  • GBP/USD

    1.2726
    -0.0003 (-0.02%)
     
  • USD/JPY

    149.2070
    +0.1090 (+0.07%)
     
  • Bitcoin USD

    65,936.20
    -1,741.43 (-2.57%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    39,469.52
    -270.92 (-0.68%)
     

Phibro Animal Health Earnings Preview

On Monday, Phibro Animal Health (NASDAQ: PAHC) will release its latest earnings report. Decipher the announcement with Benzinga's help.

Earnings and Revenue

Phibro Animal Health earnings will be near 44 cents per share on sales of $202.9 million, according to analysts.

View more earnings on PAHC

In the same quarter last year, Phibro Animal Health reported earnings per share of 37 cents on sales of $189.8 million. The Wall Street estimate would represent a 18.92 percent increase in the company's earnings. Revenue would be up 6.89 percent from the year-ago period. Here's how the Phibro Animal Health's reported EPS has stacked up against analyst estimates in the past:

Quarter

Q2 2018

Q1 2018

Q4 2017

Q3 2017

EPS Estimate

0.38

0.37

0.33

0.34

EPS Actual

0.44

0.38

0.39

0.37

Stock Performance

Over the last 52-week period, shares are up 39.87 percent. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. The most common rating from analysts on Phibro Animal Health stock is a Neutral. The strength of this rating has risen over the past three months.

See more from Benzinga

© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement